PMC:7781500 / 17287-17464 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"211","span":{"begin":38,"end":48},"obj":"Species"},{"id":"214","span":{"begin":78,"end":96},"obj":"Chemical"},{"id":"215","span":{"begin":160,"end":168},"obj":"Disease"}],"attributes":[{"id":"A211","pred":"tao:has_database_id","subj":"211","obj":"Tax:2697049"},{"id":"A214","pred":"tao:has_database_id","subj":"214","obj":"MESH:D006886"},{"id":"A215","pred":"tao:has_database_id","subj":"215","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"With its in-vitro effectivity against SARS-CoV-2 and good lung concentration, hydroxychloroquine is a drug candidate selected to be used as prophylaxis against COVID-19 [13-15]."}

    TEST0

    {"project":"TEST0","denotations":[{"id":"33409060-170-176-2361961","span":{"begin":170,"end":172},"obj":"[\"32294495\"]"}],"text":"With its in-vitro effectivity against SARS-CoV-2 and good lung concentration, hydroxychloroquine is a drug candidate selected to be used as prophylaxis against COVID-19 [13-15]."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T188","span":{"begin":0,"end":177},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"With its in-vitro effectivity against SARS-CoV-2 and good lung concentration, hydroxychloroquine is a drug candidate selected to be used as prophylaxis against COVID-19 [13-15]."}